Scott A. Gangloff - Chief Technology Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Technology Officer
Stock Symbol
AKRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Scott A. Gangloff since 9/17/2023

Holdings reported by Scott A. Gangloff for Akero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 225K Apr 29, 2024 Direct Common Stock

Transactions reported by Scott A. Gangloff for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.